top of page

Acerca de

Testimonial-2-v2.png
DSPN Member Education Opportunities

DSPN is excited to partner with our Annual Sponsors, Associate Members and Conference presenters to develop a relevant and timely member education series.

These webinars are open to all DSPN members and staff.

 

 

​​​

Recent webinars: 

​

 â€‹DSPN Annual Sponsor Jazz Pharmaceuticals - specialists in providing solutions for people living with neurological conditions & their caregivers - offered an insightful and informative, no cost online gathering for DSPN Members. 

We thank the team at Jazz Pharmaceuticals for making this session possible.

​​

​Missed the session?  Catch up with the Jazz Pharmaceuticals team at the 2024 DSPN Conference. They'll be there in-person presenting Cannabinoids 101.

​​

Access additional education 

Topic: Clinical and Non-clinical outcomes with the Use of Epidiolex in the Population of I/DD

​

Presenter: Nanette Wrobel, RPh

​

Overview: This presentation is ideal for any providers with individuals with I/DD that have refractory (continued) seizures. Hear how specialists are delivering solutions for people living with neurological conditions & their caregivers.

Any questions may be shared with Brandon Eddy, RN, National Long Term Care Account Executive - Epilepsy & Movement Disorders: Brandon.Eddy@jazzpharma.com

​​​​

​

​

​

 

 

 

 

 

 

Recent webinars: 

​​

Topic: AI Informational Webinar for DSPN Members from Therap Services 

​​

Overview:

Artificial Intelligence (AI) is all around us. DSPN Associate Member Therap Services offered an informative webinar on August 7th exploring this space. Whether you were well informed on the technology or uncertain where or how to begin, we this presentation is of value. Walk away with a practical understanding and connection to your role as a provider.  

​

​

​​​DSPN Annual Sponsor Jazz Pharmaceuticals - specialists in providing solutions for people living with neurological conditions & their caregivers - offered an insightful and informative, no cost online gathering for DSPN Members on April 3rd.

​

More about this educational presentation:

 

Topic: Medical Cannabis: Where are we now?

 

Overview:

Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation.

This presentation will provide an overview of cannabis and cannabinoid terminology, complexity of the cannabis plant and cannabinoid science, current regulations, and web-based resources available for continued learning. 

 

Key Learning Objectives:

  • Describe cannabis & cannabinoid terminology.

  • Understanding of complexity of the cannabis plant and cannabinoid science.

  • Explain known differences between FDA-approved and non-FDA-approved cannabinoid-based products.

  • Overview of current regulation of cannabis-based products in the US.

  • Share web-based resources for continued learning.

 Presenters & Bios:

  • Jennifer L Triemstra, MS, PhD – Associate Medical Director – Cannabinoid Education, US Medical Affairs, Jazz Pharmaceuticals

​

​

​

​

​

  • Daniela Sharfstein - Director Government Affairs - Jazz Pharmaceuticals 

 

Jennifer, also known as, “Trie”, is an Associate Director in Medical Affairs for Jazz Pharmaceuticals, leading the Cannabinoid Science Education program.  Trie has been working in the cannabinoid science space for nearly 7 years and was instrumental in building the content for CannabinoidClinical.com educational website and leads the Cannabinoid Education Working Group.  Trie has presented to learners across the United States including scientific and healthcare providers, advocacy groups, medical societies, state government and policy making members, and beyond the US including the UN Commission on Narcotic Drugs. 

Prior to her current role, Trie was a Medical Science Liaison at Greenwich Biosciences, US subsidiary of GW Pharmaceuticals, providing scientific support to develop an FDA-approved cannabidiol therapy for the treatment of seizures associated with epilepsy.  Trie received her Master of Science in Cellular and Molecular Biology from Saint Cloud State University and her PhD in Comparative and Molecular Biosciences at the University of Minnesota, School of Veterinary Medicine. 

​

Daniela Glick Sharfstein serves as Director of State Government Relations for Jazz Pharmaceuticals.  Prior to Jazz, Daniela was a senior consultant for Public Works, LLC where she provided high-level policy development, management, strategic planning, and implementation to state and local governments.  Daniela also served as Deputy Cabinet Secretary of Economic Development, Director of Cabinet Affairs and Deputy Director of Political, Policy and Legislative Affairs for former New Mexico Governor Bill Richardson. Daniela is a senior leader and seasoned public policy, communications, and government relations specialist. 

​

This DSPN Annual Sponsor and Associate member is ready share more fantastic training resources. Please reach out to Brandon Eddy - RN to learn more!

​

Thank you to Jazz Pharmaceuticals for making this webinar and other resources available!

JazzPharma_Logo_FullColor (2).png
Jennifer Triemstra MS PhD Assoc Med Director.jpg
Daniela Sharfstein.jpg
Therap.jpg
Vigeo Logo.png
2023 DSPN Annual Conference Bonus!

 Thank you to Vigeo Nonprofit Advising | Coaching
for the engaging and insightful webinar on March 28th!

We are pleased to offer this informative and interactive follow up opportunity. Whether you attended Is Raising More Funds Your Answer to Being an Effective Organization? Think Again! during the conference or wanted to, this is for you.

  Could not attend, but have questions? Want to know more? Contact us at support@dspn.org 
We want to help!
bottom of page